Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-21-017079
Filing Date
2021-03-23
Accepted
2021-03-23 06:04:49
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12021_altamontpharma.htm S-1 2427532
2 CERTIFICATE OF INCORPORATION fs12021ex3-1_altamont.htm EX-3.1 28099
3 BYLAWS fs12021ex3-3_altamont.htm EX-3.3 141060
4 PROMISSORY NOTE, DATED AS OF JANUARY 29, 2021, ISSUED TO THE SPONSOR fs12021ex10-1_altamont.htm EX-10.1 12305
5 CONSENT OF MARCUM LLP. fs12021ex23-1_altamont.htm EX-23.1 2640
6 CONSENT OF JOHN D. HARKEY, JR. fs12021ex99-3_altamont.htm EX-99.3 2991
7 CONSENT OF JAY SHEPARD fs12021ex99-4_altamont.htm EX-99.4 2938
8 CONSENT OF LISA WALTERS-HOFFERT fs12021ex99-5_altamont.htm EX-99.5 2931
  Complete submission text file 0001213900-21-017079.txt   2621469
Mailing Address 600 CONGRESS AVENUE 14TH FLOOR AUSTIN TX 78702
Business Address 600 CONGRESS AVENUE 14TH FLOOR AUSTIN TX 78702 512-759-6267
Altamont Pharma Acquisition Corp. (Filer) CIK: 0001845136 (see all company filings)

EIN.: 861454183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-254603 | Film No.: 21763062
SIC: 6770 Blank Checks